Literature DB >> 6756907

Prevention of emergence of bacterial resistance with the combination of sulphamethoxazole and trimethoprim.

R N Grüneberg, A M Emmerson.   

Abstract

An in vitro technique is described for testing the proposition that combining two antibiotics prevents the emergence of bacterial resistance to either. The model was applied to testing the combination of sulphamethoxazole and trimethoprim (co-trimoxazole). Under the test conditions when a doubly sensitive organism was exposed to sulphamethoxazole or trimethoprim alone, resistance to sulphamethoxazole or trimethoprim readily emerged. When exposed to both drugs together, the doubly sensitive organism was eliminated from the cultures without emergence of bacterial resistance to either drug. A sulphamethoxazole-resistant organism exposed to trimethoprim alone or to sulphamethoxazole plus trimethoprim developed trimethoprim resistance with equal facility. The experiments show that the use of sulphamethoxazole-trimethoprim prevents the emergence of bacterial resistance among doubly-sensitive strains.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6756907     DOI: 10.1007/bf02019616

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


  8 in total

1.  Bacteriological, pharmacological and clinical studies with trimethoprim-sulphonamide combinations with particular reference to the treatment of urinary infections.

Authors:  W Brumfitt; M C Faiers; R E Pursell; D S Reeves; A R Turnbull
Journal:  Postgrad Med J       Date:  1969-11       Impact factor: 2.401

2.  Trimethoprim, a sulphonamide potentiator.

Authors:  S R Bushby; G H Hitchings
Journal:  Br J Pharmacol Chemother       Date:  1968-05

3.  The microbiological rationale for the combination of sulphonamides with trimethoprim.

Authors:  R N Grüneberg
Journal:  J Antimicrob Chemother       Date:  1979-11       Impact factor: 5.790

4.  Failure to prevent emergence of bacterial resistance by combination of two antibiotics: fusidic acid and rifampicin.

Authors:  R N Grüneberg; A M Emmerson
Journal:  J Antimicrob Chemother       Date:  1980-07       Impact factor: 5.790

5.  Antibiotic sensitivities of urinary pathogens, 1971-8.

Authors:  R N Grüneberg
Journal:  J Clin Pathol       Date:  1980-09       Impact factor: 3.411

6.  Prevention of emergence of bacterial resistance by combination of two antibiotics: rifampicin and trimethoprim.

Authors:  R N Grüneberg; A M Emmerson
Journal:  J Antimicrob Chemother       Date:  1980-05       Impact factor: 5.790

7.  Trimethoprim: laboratory and clinical studies.

Authors:  J H Darrell; L P Garrod; P M Waterworth
Journal:  J Clin Pathol       Date:  1968-03       Impact factor: 3.411

8.  Prevention of emergence of bacterial resistance: no advantage in combining rifampicin and tetracycline over use of tetracycline alone.

Authors:  R N Grüneberg; A M Emmerson
Journal:  Chemotherapy       Date:  1981       Impact factor: 2.544

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.